OptiCept Technologies
2.32 SEK
-7.20 %
Less than 1K followers
OPTI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-7.20 %
-9.38 %
-7.94 %
-41.27 %
-35.01 %
-49.46 %
-77.83 %
-96.04 %
-53.99 %
OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.
Read moreMarket cap
151.14M SEK
Turnover
325.67K SEK
Revenue
17.67M
EBIT %
-317.43 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
21/5
2026
General meeting '26
29/5
2026
Interim report Q1'26
All
Research
Press releases
3rd party
ShowingAll content types
Board Change in OptiCept
DNB Carnegie Access: OptiCept Technologies: Remainder of H1 order intake to be recognised – Q4 preview
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools